REBECCA PHILLIPS: Open Payments
NPI 1891738266 · AMHERST, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,856 in 133 payments from 19 companies in 2025. Trend: 2023 $3,379 · 2024 $2,734 · 2025 $2,856
Food & beverage: $2,856
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 16 | $454 |
| Vanda Pharmaceuticals Inc. | 11 | $369 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $299 |
| Otsuka America Pharmaceutical, Inc. | 16 | $266 |
| Collegium Pharmaceutical, Inc. | 11 | $223 |
| Lundbeck LLC | 14 | $206 |
| Supernus Pharmaceuticals, Inc. | 8 | $150 |
| Alkermes, Inc. | 10 | $148 |
| ABBVIE INC. | 8 | $137 |
| Teva Pharmaceuticals USA, Inc. | 5 | $129 |
Products named: REXULTI, INGREZZA, FANAPT, CAPLYTA, Jornay PM, Qelbree, ARISTADA, VRAYLAR.
Industry payments across NY — which companies pay providers there.
